Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9657033
APP PUB NO 20150111877A1
SERIAL NO

14398061

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides tetrahydronaphthyridine and related compounds, pharmaceutical compositions, methods of inhibiting RORγ activity, reducing the amount of IL-17 in a subject, and treating immune disorders and inflammatory disorders using such tetrahydronaphthyridine and related compounds.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHME LLC126 EAST LINCOLN AVENUE RAHWAY NJ 07065

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Aicher, Thomas D Ann Arbor, US 33 404
Barr, Kenneth J Boston, US 29 436
Lapointe, Blair T Brookline, US 19 292
Simov, Vladimir South Boston, US 15 195
Stein, Karin A Mountain View, US 3 77
Thomas, William D San Jose, US 29 432
Toogood, Peter L Ann Arbor, US 18 295
Van, Huis Chad A Hartland, US 12 274
White, Catherine M Newton Center, US 11 106

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 23, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 23, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00